rs771873576
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001492.6(GDF1):c.-312-2A>G variant causes a splice acceptor, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001492.6 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GDF1 | NM_001492.6 | c.-312-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 7 | ENST00000247005.8 | NP_001483.3 | ||
CERS1 | NM_021267.5 | c.1011-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 7 | ENST00000623882.4 | NP_067090.1 | ||
GDF1 | NM_001387438.1 | c.-312-2A>G | splice_acceptor_variant, intron_variant | Intron 3 of 4 | NP_001374367.1 | |||
CERS1 | NM_001387440.1 | c.1011-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 6 | NP_001374369.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GDF1 | ENST00000247005.8 | c.-312-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 7 | 1 | NM_001492.6 | ENSP00000247005.5 | |||
CERS1 | ENST00000623882.4 | c.1011-2A>G | splice_acceptor_variant, intron_variant | Intron 6 of 7 | 1 | NM_021267.5 | ENSP00000485308.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 421486Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 221658
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Progressive myoclonic epilepsy type 8 Uncertain:1
This sequence change affects an acceptor splice site in intron 6 of the CERS1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), however the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in CERS1 cause disease. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with CERS1-related conditions. ClinVar contains an entry for this variant (Variation ID: 542131). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at